2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Urinary Bladder Neoplasms

2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Urinary Bladder Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, SK; Chen, JS; Fang, CY; Shen, CH	1

Other Studies

1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Urinary Bladder Neoplasms

Article	Year
Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells. Anti-cancer drugs, 2018, Volume: 29, Issue:1 Topics: AMP-Activated Protein Kinases; Autophagy; Cell Growth Processes; Cell Line, Tumor; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Morpholines; Protein Kinase Inhibitors; Purines; Urinary Bladder Neoplasms; Urologic Neoplasms	2018

Article

Year

Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells.

Anti-cancer drugs, 2018, Volume: 29, Issue:1

Topics: AMP-Activated Protein Kinases; Autophagy; Cell Growth Processes; Cell Line, Tumor; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Morpholines; Protein Kinase Inhibitors; Purines; Urinary Bladder Neoplasms; Urologic Neoplasms

2018